prikaz prve stranice dokumenta Clinical practice: evidence-based recommendations for the treatment of cervical dystonia with botulinum toxin
  Download
PDF 276.17 KB
Scientific paper - Review paper
Clinical practice: evidence-based recommendations for the treatment of cervical dystonia with botulinum toxin
Frontiers in Neurology, 8 (2017); 35. https://doi.org/10.3389/fneur.2017.00035
Contarino, Maria Fiorella; Van Den Dool, Joost; Balash, Yacov; Bhatia, Kailash; Giladi, Nir; Koelman, Johannes H.; Lokkegaard, Annemette; Marti, Maria J.; Postma, Miranda; Relja, Maja; Skorvanek, Matej; Speelman, Johannes D.; Zoons, Evelien; Ferreira, Joaquim J.; Vidailhet, Marie; Albanese, Alberto; Tijssen, Marina A. J. More authors...

Cite this document

Contarino, M. F., Van Den Dool, J., Balash, Y., Bhatia, K., Giladi, N., Koelman, J. H. ... Tijssen, M. A. J. (2017). Clinical practice: evidence-based recommendations for the treatment of cervical dystonia with botulinum toxin. Frontiers in Neurology, 8., 35. doi: 10.3389/fneur.2017.00035

Contarino, Maria Fiorella, et al. "Clinical practice: evidence-based recommendations for the treatment of cervical dystonia with botulinum toxin." Frontiers in Neurology, vol. 8, 2017, p. 35. https://doi.org/10.3389/fneur.2017.00035

Contarino, Maria Fiorella, Joost Van Den Dool, Yacov Balash, Kailash Bhatia, Nir Giladi, Johannes H. Koelman, Annemette Lokkegaard, et al. "Clinical practice: evidence-based recommendations for the treatment of cervical dystonia with botulinum toxin." Frontiers in Neurology 8 (2017): 35. https://doi.org/10.3389/fneur.2017.00035

Contarino, M. F., et al. (2017) 'Clinical practice: evidence-based recommendations for the treatment of cervical dystonia with botulinum toxin', Frontiers in Neurology, 8, p. 35. doi: 10.3389/fneur.2017.00035

Contarino MF, Van Den Dool J, Balash Y, Bhatia K, Giladi N, Koelman JH, and sur.. Clinical practice: evidence-based recommendations for the treatment of cervical dystonia with botulinum toxin. Frontiers in Neurology [Internet]. 2017 February 24 [cited 2024 November 29];8:35. doi: 10.3389/fneur.2017.00035

M. F. Contarino, et al., "Clinical practice: evidence-based recommendations for the treatment of cervical dystonia with botulinum toxin", Frontiers in Neurology, vol. 8, p. 35, February 2017. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:521763. [Accessed: 29 November 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Clinical practice: evidence-based recommendations for the treatment of cervical dystonia with botulinum toxin
AuthorMaria Fiorella Contarino
AuthorJoost Van Den Dool
AuthorYacov Balash
AuthorKailash Bhatia
AuthorNir Giladi
AuthorJohannes H. Koelman
AuthorAnnemette Lokkegaard
AuthorMaria J. Marti
AuthorMiranda Postma
AuthorMaja Relja
AuthorMatej Skorvanek
AuthorJohannes D. Speelman
AuthorEvelien Zoons
AuthorJoaquim J. Ferreira
AuthorMarie Vidailhet
AuthorAlberto Albanese
AuthorMarina A. J. Tijssen
Author's institutionUniversity of Zagreb
School of Medicine
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
Cervical dystonia (CD) is the most frequent form of focal dystonia. Symptoms often result in pain and functional disability. Local injections of botulinum neurotoxin are currently the treatment of choice for CD. Although this treatment has proven effective and is widely applied worldwide, many issues still remain open in the clinical practice. We performed a systematic review of the literature on botulinum toxin treatment for CD based on a question-oriented approach, with the aim to provide practical recommendations for the treating clinicians. Key questions from the clinical practice were explored. Results suggest that while the beneficial effect of botulinum toxin treatment on different aspects of CD is well established, robust evidence is still missing concerning some practical aspects, such as dose equivalence between different formulations, optimal treatment intervals, treatment approaches, and the use of supportive techniques including electromyography or ultrasounds. Established strategies to prevent or manage common side effects (including excessive muscle weakness, pain at injection site, dysphagia) and potential contraindications to this treatment (pregnancy and lactation, use of anticoagulants, neurological comorbidities) should also be further explored.
Languageenglish
Publication typeScientific paper - Review paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleFrontiers in Neurology
Numberingvol. 8, p. 35
p-ISSN1664-2295
DOIhttps://doi.org/10.3389/fneur.2017.00035
URN:NBNurn:nbn:hr:105:521763
Publication2017-02-24
Document URLhttps://doi.org/10.3389/fneur.2017.00035
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2024-03-28 09:05:03